These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Feb 28, 2013Agenus to Host Conference Call Beginning at 11 a.m. ET Today
Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today announced its financial results and business...
Feb 27, 2013HerpV is clinically the most advanced therapeutic vaccine for the treatment of genital herpes
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced it has completed patient screening in its Phase 2 randomized, double-blind,...
Feb 26, 2013
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the Cowen and Company 33rd Annual...
Feb 21, 2013Agenus to Report Fourth Quarter and Year End 2012 Financial Results on February 28, 2013; Conference Call to Follow
Agenus Inc. (NASDAQ: AGEN) will release its fourth quarter and year ended December 31, 2012 financial results before the market opens on February 28, 2013. Agenus executives will host a conference...